Compare · RGC vs UPXI
RGC vs UPXI
Side-by-side comparison of Regencell Bioscience Holdings Limited (RGC) and Upexi Inc. (UPXI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RGC and UPXI operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $10.58B, about 158.4x UPXI ($66.8M).
- Over the past year, RGC is up 34.4% and UPXI is down 91.8% - RGC leads by 126.2 points.
- RGC has hit the wire 6 times in the past 4 weeks while UPXI has been quiet.
- UPXI has more recent analyst coverage (2 ratings vs 0 for RGC).
PerformanceRGC+34.37%UPXI-91.83%
2025-06-09+0.00%2026-06-08
- Company
- Regencell Bioscience Holdings Limited
- Upexi Inc.
- Price
- $21.58+7.42%
- $0.98+3.33%
- Market cap
- $10.58B
- $66.8M
- 1M return
- -32.29%
- -27.77%
- 1Y return
- +34.37%
- -91.83%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 6
- 0
- Recent ratings
- 0
- 2
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
Latest UPXI
- Amendment: SEC Form SCHEDULE 13G/A filed by Upexi Inc.
- Upexi Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Upexi Inc.
- Upexi Reports Fiscal Third Quarter 2026 Financial Results
- Upexi Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Upexi to Present at the LD Micro Invitational XVI Conference on May 17-19
- Upexi Provides Periodic Update to its Share Repurchase Program
- Upexi to Host Third Quarter 2026 Earnings Call on May 12th at 5:30 p.m. ET
- SEC Form DEF 14A filed by Upexi Inc.
- Upexi Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits